Judy Airebamen

Imaging-based biological age estimation predicts competing mortality risk in lung cancer screening

Abstract Lung cancer screening (LCS) participants have a high competing risk of non-lung cancer related death, which limits screening benefit. We hypothesized that imaging-based biological age can identify individuals at higher risk of non-lung cancer mortality. Low dose computed...